Tenacia Biotechnology

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regeneron Bolsters Ophthalmic Portfoli

At least five biopharma companies have filed paperwork with the US Securities and Exchange Commission (SEC) since the start of 2024 to signal their intention to go public this year, entering what stil

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Novartis To Pay Argo $185m Up Fron

Marinus Pharmaceuticals, Inc. ’s Ztalmy (ganaxolone) won European Commission approval in July 2023 as an oral treatment for seizures associated with a rare, genetic pediatric-onset epilepsy disorder.